News >>

News

Recent news

Publications

News

2015/4/7 USA Patent Issued ” MODULATORS OF HEC1 ACTIVITY AND METHODS THEREFOR”. (2nd generation compound)

2015/2/3 USA Patent Issued ” MODULATORS OF HEC1 ACTIVITY AND METHODS THEREFOR”.


2014/9/12 Australia Patent Issued ” MODULATORS OF HEC1 ACTIVITY AND METHODS THEREFOR”.


2014/8/30 New Zealand Patent Allowed” MODULATORS OF HEC1 ACTIVITY AND METHODS THEREFOR”.


2012/8/28 US Patent Allowed "METHODS AND COMPOUNDS FOR INHIBITING HEC1 ACTIVITY FOR THE TREATMENT OF PROLIFERATIVE DISEASES"


2011/12/14 Nek2/Hec1 inhibitor, which was a first-in-class anti-cancer drug lead, and jointly developed by Taivex and Development Center for Biotechnology (DCB), win the 2011 Breakthrough Innovation of the Year Award .